Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market
The FDA approval of the Wegovy pill highlights many of the key themes Novo Nordisk will have to face in…
The FDA approval of the Wegovy pill highlights many of the key themes Novo Nordisk will have to face in…
The moves come at the end of a blockbuster year of annual gains for the precious metals. ...
In a social media post on X, the Scion Asset Management founder responded to a user asking if he would…
Trump promised retribution after Colorado refused to release Tina Peters, who was convicted by a state court last year. ...
Big Tech is remaking the U.S. map into an AI empire — kingdom-scale data centers, unprecedented debt, power constraints, and…
Asia-Pacific markets were poised for modest gains on the holiday-shortened and final trading day of the year. ...
China’s economy ended the year on a slightly less gloomy note as manufacturing, services and construction activity all improved in…
Companies have been spending big on AI infrastructure to support growing compute and connectivity needs. ...
Housing is getting more affordable thanks to lower prices and lower mortgage rates, but it still takes more time to…